CAS 1238217-55-4

Vatelizumab

CAS: 1238217-55-4

Humanized monoclonal antibody targeting integrin alpha 2; immunomodulator

Ref: 3D-CLA1287

Vatelizumab

CAS: 1238217-55-4

Vatelizumab is a humanised monoclonal antibody targeting Integrin α2β1 ( VLA-2, CD49b), which enhances the frequency of regulatory T cells multiple sclerosis.

Reinheit: 95%

Farbe und Form: Liquid

Molekulargewicht: ~150 kDa

Ref: TM-T80875